Syngene International

Syngene International Limited is a leading contract research and manufacturing organization (CRO/CMO) with a global presence, offering a comprehensive suite of services across the drug discovery and development value chain. Their services span diverse therapeutic areas and cater to a wide range of clients including pharmaceutical, biotechnology, animal health, and other industries. Their geographical reach extends to India, the United States, Europe, and other international markets, highlighting their established global network and capacity.

Syngene's services in drug discovery encompass a broad spectrum, from early-stage research to preclinical development. This includes expertise in discovery chemistry (synthetic and medicinal chemistry, library and peptide synthesis, etc.), discovery biology (recombinant DNA engineering, cell line development, and various other biological assays), and computational and analytical chemistry. They also provide lead generation services crucial for initiating drug development pipelines.

Beyond drug discovery, Syngene offers extensive development and manufacturing capabilities. Their services include chemical, formulation, analytical, and clinical development, along with commercial manufacturing and sterile fill-finish capabilities. This ensures a seamless transition from discovery to commercialization for their clients. They also provide crucial support services for clinical trials, including management, data management, bioanalysis, and regulatory support.

Syngene's capabilities extend beyond traditional small molecule therapeutics. They possess expertise in biologics, peptides, oligonucleotides, antibody-drug conjugates, and targeted degradation/stabilization technologies, showcasing their adaptability to emerging therapeutic modalities. Their integrated approach combining chemistry, biology, safety assessment, computational, and data sciences provides a holistic solution for clients seeking comprehensive drug development partnerships.

The company boasts significant collaborations with prominent pharmaceutical giants such as Bristol-Myers Squibb, Baxter Inc., and Amgen Inc., underscoring its reputation and the quality of services provided. Established in 1993 and headquartered in Bengaluru, India, Syngene is a subsidiary of Biocon Limited, benefiting from the parent company's experience and resources within the broader pharmaceutical landscape.